US Patent Issued to XinThera on Sept. 23 for "Substituted pyridines as PARP1 inhibitors" (California Inventors)

ALEXANDRIA, Va., Sept. 23 -- United States Patent no. 12,421,241, issued on Sept. 23, was assigned to XinThera Inc. (Foster City, Calif.).

"Substituted pyridines as PARP1 inhibitors" was invented by Robert L. Hoffman (San Diego), Porino Jinjo Va (San Diego), Joseph Robert Pinchman (San Diego), Qing Dong (San Diego) and Stephen W. Kaldor (San Diego).

According to the abstract* released by the U.S. Patent & Trademark Office: "Described herein are tricyclic PARP1 inhibitors and pharmaceutical compositions comprising said inhibitors. The subject compounds and compositions are useful for the treatment of cancer."

The patent was filed on May 2, 2024, under Application No. 18/653,538.

*For further information, including images, charts and tabl...